XEGLYZE (abametapir) Hatchtech Patent: 8,212,038 Expiration: Jul 16, 2024 See More … For more information on how DrugPatentWatch can help […]
Drug Patent Expirations for the Week of July 14, 2024 Read Post »
Annual Drug Patent Expirations for XEGLYZE Xeglyze is a drug marketed by Hatchtech and is included in one NDA. It
New patent expiration for Hatchtech drug XEGLYZE Read Post »
Annual Drug Patent Expirations for ORENITRAM Orenitram is a drug marketed by United Therap and is included in one NDA.
New patent expiration for United Therap drug ORENITRAM Read Post »
Annual Drug Patent Expirations for ORILISSA Orilissa is a drug marketed by Abbvie and is included in one NDA. It
ORILISSA (elagolix sodium) Abbvie Patent: 7,176,211 Expiration: Jul 6, 2024 See More … For more information on how DrugPatentWatch can
Drug Patent Expirations for the Week of June 30, 2024 Read Post »
Annual Drug Patent Expirations for MOVANTIK Movantik is a drug marketed by Valinor and is included in one NDA. It
MOVANTIK (naloxegol oxalate) Valinor Patent: 7,056,500 Expiration: Jun 29, 2024 See More … For more information on how DrugPatentWatch can
Drug Patent Expirations for the Week of June 23, 2024 Read Post »
MOVANTIK (naloxegol oxalate) Valinor Patent: 7,056,500 Expiration: Jun 29, 2024 See More … For more information on how DrugPatentWatch can
Drug Patent Expirations for the Week of June 23, 2024 Read Post »
Annual Drug Patent Expirations for XIFAXAN Xifaxan is a drug marketed by Salix Pharms and is included in one NDA.
New patent expiration for Salix Pharms drug XIFAXAN Read Post »
Get fresh news and insights, drug patent expirations & more…
